Source: Annual Congress 2007 - Novel therapies for severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Pavord (Leicester, United Kingdom). Treating smooth muscle medically: anti-TNF treatment. Annual Congress 2007 - Novel therapies for severe asthma

Member's Comments

No comment yet.

Related content which might interest you: Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations Source: Eur Respir J 2004; 24 : 659-663 Year: 2004 Give me the patient's smooth muscle cells and I will tell you how to develop effective anti-asthma therapy – Pro Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 Treating smooth muscle physically: bronchial thermoplasty Source: Annual Congress 2007 - Novel therapies for severe asthma Year: 2007 Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Give me the patient's smooth muscle cells and I will tell you how to develop effective anti-asthma therapy – Con Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Airway smooth muscle thickness in asthma is related to severity but not duration of asthma Source: Eur Respir J 2009; 34: 1040-1045 Year: 2009 Characteristics of asthma patients responding to anti-IgE therapy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Treating asthma means treating airway smooth muscle cells Source: Eur Respir J 2008; 32: 265-274 Year: 2008 Audit of bronchial thermoplasty patients who did not complete their treatment session as planned Source: International Congress 2016 – Asthma management Year: 2016 Effect of nilotinib on airway smooth muscle thickening in a murine model of chronic asthma Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 The critical role of bronchial smooth muscle remodeling in non-severe asthma Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults Source: Eur Respir Rev 2014; 23: 510-518 Year: 2014 Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Add-on omalizumab therapy for patients with severe persistent allergic (IgE-mediated) asthma: identifying which patients to treat and which patients respond Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019